Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

OBJECTIVE: To compare the market dynamics of biosimilar infliximab among four Organization for Economic Cooperation and Development (OECD) countries (UK, France, Japan, and Korea) where supply-side and demand-side policies varied greatly, given high and growing expenditure on biological medicines to...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Kim, Yujeong, Kwon, Hye-Young, Godman, Brian, Moorkens, Evelien, Simoens, Steven, Bae, SeungJin
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7363801/
https://ncbi.nlm.nih.gov/pubmed/32733238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00970
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы